Table of Contents
ISRN Nephrology
Volume 2013 (2013), Article ID 797620, 7 pages
http://dx.doi.org/10.5402/2013/797620
Review Article

Diabetes Insipidus: A Challenging Diagnosis with New Drug Therapies

Division of Nephrology, Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA

Received 31 January 2013; Accepted 21 February 2013

Academic Editors: M. Léone and D. Malhotra

Copyright © 2013 Chadi Saifan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Lindholm, “Diabetes insipidus: historical aspects,” Pituitary, vol. 7, no. 1, pp. 33–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. G. Verbalis, “Diabetes insipidus,” Reviews in Endocrine and Metabolic Disorders, vol. 4, no. 2, pp. 177–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Maghnie, G. Cosi, E. Genovese et al., “Central diabetes insipidus in children and young adults,” The New England Journal of Medicine, vol. 343, no. 14, pp. 998–1007, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Kristof, M. Rother, G. Neuloh, and D. Klingmüller, “Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study: clinical article,” Journal of Neurosurgery, vol. 111, no. 3, pp. 555–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Y. Yap, C. K. Tashima, G. R. Blumenschein, and N. Eckles, “Diabetes insipidus and breast cancer,” Archives of Internal Medicine, vol. 139, no. 9, pp. 1009–1011, 1979. View at Publisher · View at Google Scholar · View at Scopus
  6. A. I. Rosenzweig and J. W. Kendall, “Diabetes insipidus as a complication of acute leukemia,” Archives of Internal Medicine, vol. 117, no. 3, pp. 397–400, 1966. View at Publisher · View at Google Scholar
  7. P. Hadjizacharia, E. O. Beale, K. Inaba, L. S. Chan, and D. Demetriades, “Acute diabetes insipidus in severe head injury: a prospective study,” Journal of the American College of Surgeons, vol. 207, no. 4, pp. 477–484, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Boughey, M. J. Yost, and R. P. Bynoe, “Diabetes insipidus in the head-injured patient,” The American Surgeon, vol. 70, no. 6, pp. 500–503, 2004. View at Google Scholar · View at Scopus
  9. J. A. Durr, “Diabetes insipidus in pregnancy,” American Journal of Kidney Diseases, vol. 9, no. 4, pp. 276–283, 1987. View at Google Scholar · View at Scopus
  10. M. F. Arthus, M. Lonergan, M. J. Crumley et al., “Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus,” Journal of the American Society of Nephrology, vol. 11, no. 6, pp. 1044–1054, 2000. View at Google Scholar · View at Scopus
  11. K. E. Barrett, Ganong's Review of Medical Physiology, McGraw-Hill, New York, NY, USA, 23rd edition, 2009.
  12. H. M. Kronenberg, S. Melmed, K. S. Polonsky, and P. Reed Larsen, Williams Textbook of Endocrinology, Saunders, 11th edition, 2008.
  13. D. L. Kasper, Ed., Harrison's Principles of Internal Medicine, McGraw-Hill, New York, NY, USA, 17th edition, 2008.
  14. A. W. Cowley Jr., E. Monos, and A. C. Guyton, “Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog,” Circulation Research, vol. 34, no. 4, pp. 505–514, 1974. View at Google Scholar · View at Scopus
  15. J. J. Grantham and M. B. Burg, “Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules,” The American Journal of Physiology, vol. 211, no. 1, pp. 255–259, 1966. View at Google Scholar · View at Scopus
  16. G. Fejes-Toth and A. Naray-Fejes-Toth, “Isolated principal and intercalated cells: hormone responsiveness and Na+-K+-ATPase activity,” American Journal of Physiology, vol. 256, no. 4, pp. F742–F750, 1989. View at Google Scholar · View at Scopus
  17. J. E. Kaufmann, A. Oksche, C. B. Wollheim, G. Günther, W. Rosenthal, and U. M. Vischer, “Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP,” Journal of Clinical Investigation, vol. 106, no. 1, pp. 107–116, 2000. View at Google Scholar · View at Scopus
  18. A. Morel, A. M. O'Carroll, M. J. Brownstein, and S. J. Lolait, “Molecular cloning and expression of a rat Vla arginine vasopressin receptor,” Nature, vol. 356, no. 6369, pp. 523–526, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Sugimoto, M. Saito, S. Mochizuki, Y. Watanabe, S. Hashimoto, and H. Kawashima, “Molecular cloning and functional expression of a cDNA encoding the human V(1b) vasopressin receptor,” Journal of Biological Chemistry, vol. 269, no. 43, pp. 27088–27092, 1994. View at Google Scholar · View at Scopus
  20. J. H. Christensen, C. Siggaard, and S. Rittig, “Autosomal dominant familial neurohypophyseal diabetes insipidus,” APMIS. Supplementum, vol. 111, no. 109, pp. 92–95, 2003. View at Google Scholar · View at Scopus
  21. S. S. Najjar, M. G. Saikaly, G. M. Zaytoun, and A. Abdelnoor, “Association of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. The Wolfram or DIDMOAD syndrome,” Archives of Disease in Childhood, vol. 60, no. 9, pp. 823–828, 1985. View at Google Scholar · View at Scopus
  22. N. Aleksandrov, F. Audibert, M. J. Bedard, M. Mahone, F. Goffinet, and I. J. Kadoch, “Gestational diabetes insipidus: a review of an underdiagnosed condition,” Journal of Obstetrics and Gynaecology Canada, vol. 32, no. 3, pp. 225–231, 2010. View at Google Scholar · View at Scopus
  23. D. G. Bichet, “Vasopressin receptor mutations in nephrogenic diabetes insipidus,” Seminars in Nephrology, vol. 28, no. 3, pp. 245–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. I. Nedvetsky, G. Tamma, S. Beulshausen, G. Valenti, W. Rosenthal, and E. Klussmann, “Regulation of aquaporin-2 trafficking,” Handbook of Experimental Pharmacology, no. 190, pp. 133–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Brenner & Rector's the Kidney, 9th edition, 2011.
  26. D. Marples, S. Christensen, E. I. Christensen, P. D. Ottosen, and S. Nielsen, “Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla,” Journal of Clinical Investigation, vol. 95, no. 4, pp. 1838–1845, 1995. View at Google Scholar · View at Scopus
  27. D. Marples, J. Frøkiær, J. Dørup, M. A. Knepper, and S. Nielsen, “Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex,” Journal of Clinical Investigation, vol. 97, no. 8, pp. 1960–1968, 1996. View at Google Scholar · View at Scopus
  28. J. M. Sands, F. X. Flores, A. Kato et al., “Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats,” American Journal of Physiology, vol. 274, no. 5, pp. F978–F985, 1998. View at Google Scholar · View at Scopus
  29. J. Frokiaer, D. Marples, M. A. Knepper, and S. Nielsen, “Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney,” American Journal of Physiology, vol. 270, no. 4, pp. F657–F668, 1996. View at Google Scholar · View at Scopus
  30. C. Li, W. Wang, T. H. Kwon et al., “Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect,” American Journal of Physiology, vol. 281, no. 1, pp. F163–F171, 2001. View at Google Scholar · View at Scopus
  31. A. M. Moses, “Clinical and laboratory observations in the adult with diabetes insipidus and related syndromeseds,” in Diabetes Insipidus in Man. Frontiers of Hormone Research, P. Czernichow and A. G. Robinson, Eds., vol. 13, p. 156, S Karger, Basel, Switzerland, 1985. View at Google Scholar
  32. G. L. Robertson, “Diagnosis of diabetes insipidus,” in Diabetes Insipidus in Man. Frontiers of Hormone Research, P. Czernichow and A. G. Robinson, Eds., vol. 13, p. 176, S Karger, Basel, Switzerland, 1985. View at Google Scholar
  33. P. H. Baylis, “Diabetes insipidus,” Medicine, vol. 25, pp. 9–11, 1997. View at Google Scholar
  34. S. Ananthakrishnan, “Diabetes insipidus in pregnancy: etiology, eva luation, and management,” Endocrine Practice, vol. 15, no. 4, pp. 377–382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. B. D. Rose and T. W. Post, Clinical Physiology of Acid-Base and Electrolyte Disordersed, McGraw-Hill, New York, NY, USA, 5th edition, 2001.
  36. M. Miller, T. Dalakos, A. M. Moses, H. Fellerman, and D. H. Streeten, “Recognition of partial defects in antidiuretic hormone secretion,” Annals of Internal Medicine, vol. 73, no. 5, pp. 721–729, 1970. View at Google Scholar · View at Scopus
  37. R. L. Zerbe and G. L. Robertson, “A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria,” The New England Journal of Medicine, vol. 305, no. 26, pp. 1539–1546, 1981. View at Google Scholar · View at Scopus
  38. G. L. Robertson, “Diseases of the posterior pituitary,” in Endocrinology and Metabolism, D. Felig, J. D. Baxter, A. E. Broadus, and L. A. Frohman, Eds., pp. 251–277, McGraw-Hill, New York, NY, USA, 1981. View at Google Scholar
  39. M. Miller, T. Dalakos, A. M. Moses, H. Fellerman, and D. H. Streeten, “Recognition of partial defects in antidiuretic hormone secretion,” Annals of Internal Medicine, vol. 73, no. 5, pp. 721–729, 1970. View at Google Scholar · View at Scopus
  40. R. L. Zerbe and G. L. Robertson, “A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria,” The New England Journal of Medicine, vol. 305, no. 26, pp. 1539–1546, 1981. View at Google Scholar · View at Scopus
  41. K. S. L. Lam, M. S. Wat, K. L. Choi, T. P. Ip, R. W. C. Pang, and C. R. Kumana, “Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus,” British Journal of Clinical Pharmacology, vol. 42, no. 3, pp. 379–385, 1996. View at Google Scholar · View at Scopus
  42. R. M. Lane, “SSRIs and hyponatraemia,” The British Journal of Clinical Practice, vol. 51, no. 3, pp. 144–146, 1997. View at Google Scholar · View at Scopus
  43. A. C. De Bragana, Z. P. Moyses, and A. J. Magaldi, “Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression,” Nephrology Dialysis Transplantation, vol. 25, no. 12, pp. 3840–3845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. D. Cook, Y. H. Caplan, C. P. LoDico, and D. M. Bush, “The characterization of human urine for specimen validity determination in workplace drug testing: a review,” Journal of Analytical Toxicology, vol. 24, no. 7, pp. 579–588, 2000. View at Google Scholar · View at Scopus